Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy

Jan 15 2021

• By Ian Haydock, Joseph Haas, and Jung Won Shin

Asia Deal Watch

Related Content

Merck & Co Takes Up Astex/Taiho SHP2 Program

Jan 13 2021

BeiGene Ties Up With Novartis To Take PD-1 Global In $2.2bn+ Deal

Jan 12 2021

The Pandemic Hurt, But EY Expects More Biopharma Deal-Making In 2021

Jan 11 2021

GC LabCell Taps Alliances In Bid For Lead NK Cell Position

Jan 08 2021

Asia Deal Watch: China Grand, ETheRNA Create mRNA Vaccine JV

Dec 03 2020

Related Companies

Takeda Pharmaceutical Co. Ltd.

KSQ Therapeutics

Astellas Pharma, Inc.

Actinium Pharmaceuticals, Inc.

Whitehawk Therapeutics, Inc.

EOC Pharma Group

Strand Therapeutics Inc.

BeOne Medicines Ltd.

HUTCHMED (China) Limited

ImageneBio, Inc.

Alteogen Inc.

Intas Pharmaceuticals Ltd.

Allergan plc

Y-Biologics Inc.

3D Medicines Inc.

LigaChem Biosciences

Pyxis Oncology

Additional Topics

Asia Pacific Deals Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.